Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Procko

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Neurobiology of Disease|July 17, 2018
Reduced axonal surface expression and phosphoinositide sensitivity in K<sub>v</sub>7 channels disrupts their function to inhibit neuronal excitability in Kcnq2 epileptic encephalopathyEung Chang Kim, Jiaren Zhang, Weilun Pang, et al.
Science Advances|February 24, 2023
Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypesYi Sun, Georgia F Papadaki, Christine A Devlin, et al.
Biorxiv : the Preprint Server for Biology|April 5, 2022
An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2Lianghui Zhang, Krishna K Narayanan, Laura Cooper, et al.
Journal of Molecular Biology|July 6, 2013
Computational design of a protein-based enzyme inhibitorErik Procko, Rickard Hedman, Keith Hamilton, et al.
Scientific Reports|March 18, 2020
Identifying mutation hotspots reveals pathogenetic mechanisms of KCNQ2 epileptic encephalopathyJiaren Zhang, Eung Chang Kim, Congcong Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2019
Molecular determinants of chaperone interactions on MHC-I for folding and antigen repertoire selectionAndrew C McShan, Christine A Devlin, Sarah A Overall, et al.
Molecular Metabolism|September 12, 2021
The Ile191Val is a partial loss-of-function variant of the TAS1R2 sweet-taste receptor and is associated with reduced glucose excursions in humansJoan Serrano, Jaroslava Seflova, Jihye Park, et al.
EMBO Molecular Medicine|September 12, 2022
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV-2Lianghui Zhang, Krishna K Narayanan, Laura Cooper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2015
Intracellular delivery system for antibody-Peptide drug conjugatesGeoffrey Y Berguig, Anthony J Convertine, Shani Frayo, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 VariantsLianghui Zhang, Soumajit Dutta, Shiqin Xiong, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Neurobiology of Disease|July 17, 2018
Reduced axonal surface expression and phosphoinositide sensitivity in K<sub>v</sub>7 channels disrupts their function to inhibit neuronal excitability in Kcnq2 epileptic encephalopathyEung Chang Kim, Jiaren Zhang, Weilun Pang, et al.
Science Advances|February 24, 2023
Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypesYi Sun, Georgia F Papadaki, Christine A Devlin, et al.
Biorxiv : the Preprint Server for Biology|April 5, 2022
An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2Lianghui Zhang, Krishna K Narayanan, Laura Cooper, et al.
Journal of Molecular Biology|July 6, 2013
Computational design of a protein-based enzyme inhibitorErik Procko, Rickard Hedman, Keith Hamilton, et al.
Scientific Reports|March 18, 2020
Identifying mutation hotspots reveals pathogenetic mechanisms of KCNQ2 epileptic encephalopathyJiaren Zhang, Eung Chang Kim, Congcong Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2019
Molecular determinants of chaperone interactions on MHC-I for folding and antigen repertoire selectionAndrew C McShan, Christine A Devlin, Sarah A Overall, et al.
Molecular Metabolism|September 12, 2021
The Ile191Val is a partial loss-of-function variant of the TAS1R2 sweet-taste receptor and is associated with reduced glucose excursions in humansJoan Serrano, Jaroslava Seflova, Jihye Park, et al.
EMBO Molecular Medicine|September 12, 2022
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV-2Lianghui Zhang, Krishna K Narayanan, Laura Cooper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2015
Intracellular delivery system for antibody-Peptide drug conjugatesGeoffrey Y Berguig, Anthony J Convertine, Shani Frayo, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 VariantsLianghui Zhang, Soumajit Dutta, Shiqin Xiong, et al.
Pageof 6